Signal Desk · Companies

JSW Steel, Dr Reddy’s, Mankind Pharma discuss AI investment balance

2026-11-20 · 1 source · Economic Times CFO

In short

Finance leaders from JSW Steel, Dr. Reddy’s Laboratories, Mankind Pharma, ClearTax and Ripple Treasury spoke at the inaugural ETCFO Annual Conclave 2026 about AI spending. They discussed how companies can balance AI investment with financial returns, efficiency and long-term change.

The panel said data readiness, phased spending and governance are important for making AI pay off in real business results.

What the reporting says

Finance leaders from JSW Steel, Dr. Reddy’s Laboratories, Mankind Pharma, ClearTax and Ripple Treasury discussed how enterprises are balancing AI investments with financial returns, operational efficiency and long-term transformation at the inaugural ETCFO Annual Conclave 2026. The discussion stressed data readiness, phased spending and governance as ways to turn AI adoption into measurable business outcomes. The remarks point to a cautious but active corporate approach to AI spending.

Why it matters

At the inaugural ETCFO Annual Conclave 2026, finance leaders from JSW Steel, Dr. Reddy’s Laboratories, Mankind Pharma, ClearTax and Ripple Treasury discussed how companies are weighing AI spending against returns and efficiency. The source highlights data readiness, phased investments and governance as the path to measurable results. The story matters for the named firms and other large enterprises considering AI budgets and implementation strategy.

Touches: JSW Steel, Dr. Reddy’s Laboratories, Mankind Pharma, ClearTax, Ripple Treasury, AI, Companies

Sources